This program combines groundbreaking GLP-1 medications, lab testing, and the knowledge of leading clinicians to create a highly effective approach to weight loss
Click below to learn more about our referral program
Plus, we offer nutritional counseling and behavior modifications for even better outcomes
People with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, pancreatitis, or severe gastrointestinal conditions should avoid GLP1 weight-loss drugs unless specifically advised by their physician
3.3.4 MGBA alterations and pathophysiological mechanisms in anxiety Rodent models of anxiety disorders provide causal evidence that stress exposure disrupts the MGBA, leading to microbiota alterations, compromised gut barrier integrity, immune activation and neurotransmitter imbalance (Bear et al., 2021)